Skip to main content
. Author manuscript; available in PMC: 2021 Oct 13.
Published in final edited form as: Surgery. 2019 Sep 24;167(1):233–240. doi: 10.1016/j.surg.2019.06.052

Fig 4.

Fig 4.

Migration and invasion of NCI-H295R and SW13 cells decreases after treatment with KU758 in a dose-dependent manner with total inhibition of migration and invasion at 2.0 μM and 4.0 μM KU758 in NCI-H295R and SW13 cells, respectively. Migration and invasion after treatment of ACC cells with 1.0 μM 17-AAG are shown for comparison. ACC, adrenocortical carcinoma.